Trials / Completed
CompletedNCT05111613
The PEERLESS Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 692 (actual)
- Sponsor
- Inari Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, multicenter, randomized controlled trial of the FlowTriever System compared to Catheter-Directed Thrombolysis (CDT) for use in the treatment of acute pulmonary embolism. The trial includes a non-randomized cohort of subjects with an absolute contraindication to thrombolysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Catheter-Directed Thrombolysis | Catheter-Directed Thrombolysis for pulmonary embolism (any commercially available CDT system) |
| DEVICE | FlowTriever System | Mechanical thrombectomy for pulmonary embolism |
Timeline
- Start date
- 2022-02-14
- Primary completion
- 2024-03-01
- Completion
- 2024-04-11
- First posted
- 2021-11-08
- Last updated
- 2025-11-13
- Results posted
- 2025-11-13
Locations
60 sites across 3 countries: United States, Germany, Switzerland
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05111613. Inclusion in this directory is not an endorsement.